In the months after the 2024 election and before President Donald Trump’s second inauguration, healthcare executives paid ...

HHS Secretary Robert F. Kennedy Jr. said any staffers in the department who are "working for the pharmaceutical industry" ...

AstraZeneca is paying $160 million for FibroGen’s China business, giving the U.K.-based Big Pharma the regional rights to ...

Much to the Democrats’ chagrin, Robert F. Kennedy Jr. is now the United States’ new Health and Human Services secretary.

President Donald Trump will meet with major drugmakers' executives to discuss drug pricing and insurance changes. Key topics ...

Zealand’s CEO Adam Steensberg said that the company is “exactly where it wants to be” in terms of its partnering and ...

Harmony Biosciences is facing more of a nightmare than sweet dreams on the road to securing a new use for its excessive ...

Independent journalist Brittney Hopper says Health and Human Services Secretary RFK Jr wants to “expose corruption” in the FDA and big pharma. “Regardless of what you think about this man personally ...

In this edition of “Psychedelic”, The Fly conducted an exclusive interview with Joseph Tucker, Chief Executive Officer and Director of Enveric ...

An index of Indian pharmaceutical company shares slid 2% to its lowest level in seven months on Wednesday after U.S.

Swedish biotech company Gesynta Pharma AB has secured $27 million in a Series B financing round led by Innovestor Life Science in Finland.

Explore AC Immune's innovative Alzheimer's and Parkinson's therapies, key pharma collaborations, and financial outlook. Learn more on ACIU stock here.